It has been addressed, specifically in the progression of breast cancer metastasis that those factors repressed VEGF-C-mediated signaling can reduce the risk of lymph node metastasis and hold the promising potential to further address improvements on cancer survival15. This evidence concerns the gene VEGFC and breast carcinoma.